Myeloid Marker Blocking Peptide peptide (STJ505506)
SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 200-250 on human Dual serine/threonine and tyrosine protein kinase protein (RIPK5).
General Information
| Short Description | Myeloid Marker Blocking Peptide is synthetically produced from the 200-250 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20ยฐC for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Gene Symbol | Myadm |
| Gene ID | 369016 |
| Uniprot ID | MYADM_RAT |
| Immunogen | Synthetic peptide taken within amino acid region 200-250 on human Dual serine/threonine and tyrosine protein kinase protein (RIPK5). |
| Immunogen Region | 200-250 |
Additional Info
| Cellular Localisation | MembraneMulti-Pass Membrane Protein |
| Alternative Peptide Names | Myeloid-Associated Differentiation Marker proteinMyeloid Up-Regulated Protein proteinMyadm protein |
Information sourced from Uniprot.org